Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duvivier

Showing results (461-470 of 505) with videos related to

Pageof 51
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 14, 2020
Spectrum and Incidence Trends of AIDS- and Non-AIDS-Defining Cancers between 2010 and 2015 in the French Dat'AIDS CohortIsabelle Poizot-Martin, Caroline Lions, Clotilde Allavena, et al.
HIV Medicine|February 2, 2018
Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in EuropeJ R Santos, A Cozzi-Lepri, A Phillips, et al.
BMJ Open|July 18, 2025
Preoperative partial breast reirradiation and repeat breast-conserving surgery in patients with recurrent breast cancer: the prospective single-arm REPEAT trial - a study protocolYasmin Civil, Lisca Wurfbain, Lysanne Jonker, et al.
BMJ Public Health|November 20, 2025
Association between late access to care and mortality for PWH: insights from the French Hospital Database on HIV (ANRS CO4-FHDH) from 2002 to 2016Valérie Potard, Fabienne Caby, Malamine Gassama, et al.
JCO Precision Oncology|June 14, 2023
Pertuzumab Plus Trastuzumab in Patients With Lung Cancer With <i>ERBB2</i> Mutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry StudyApar K Ganti, Michael Rothe, Pam K Mangat, et al.
HIV Medicine|May 18, 2016
Psychiatric and substance use disorders in HIV/hepatitis C virus (HCV)-coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS) HEPAVIH CO13 cohort]L Michel, C Lions, M Winnock, et al.
JCO Precision Oncology|June 12, 2024
Talazoparib in Patients With Solid Tumors With <i>BRCA1</i>/<i>2</i> Mutation: Results From the Targeted Agent and Profiling Utilization Registry StudyGordan Srkalovic, Michael Rothe, Pam K Mangat, et al.
AIDS (London, England)|August 23, 2018
Aging and the evolution of comorbidities among HIV-positive individuals in a European cohortAnnegret Pelchen-Matthews, Lene Ryom, Álvaro H Borges, et al.
JCO Precision Oncology|November 21, 2022
Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With <i>BRAF</i> Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) StudyKelsey A Klute, Michael Rothe, Elizabeth Garrett-Mayer, et al.
HIV Medicine|December 10, 2021
The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA studyAmanda Mocroft, Jose M Miro, Gilles Wandeler, et al.
Pageof 51

Showing results (461-470 of 505) with videos related to

Sort By:
Pageof 51
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 14, 2020
Spectrum and Incidence Trends of AIDS- and Non-AIDS-Defining Cancers between 2010 and 2015 in the French Dat'AIDS CohortIsabelle Poizot-Martin, Caroline Lions, Clotilde Allavena, et al.
HIV Medicine|February 2, 2018
Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in EuropeJ R Santos, A Cozzi-Lepri, A Phillips, et al.
BMJ Open|July 18, 2025
Preoperative partial breast reirradiation and repeat breast-conserving surgery in patients with recurrent breast cancer: the prospective single-arm REPEAT trial - a study protocolYasmin Civil, Lisca Wurfbain, Lysanne Jonker, et al.
BMJ Public Health|November 20, 2025
Association between late access to care and mortality for PWH: insights from the French Hospital Database on HIV (ANRS CO4-FHDH) from 2002 to 2016Valérie Potard, Fabienne Caby, Malamine Gassama, et al.
JCO Precision Oncology|June 14, 2023
Pertuzumab Plus Trastuzumab in Patients With Lung Cancer With <i>ERBB2</i> Mutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry StudyApar K Ganti, Michael Rothe, Pam K Mangat, et al.
HIV Medicine|May 18, 2016
Psychiatric and substance use disorders in HIV/hepatitis C virus (HCV)-coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS) HEPAVIH CO13 cohort]L Michel, C Lions, M Winnock, et al.
JCO Precision Oncology|June 12, 2024
Talazoparib in Patients With Solid Tumors With <i>BRCA1</i>/<i>2</i> Mutation: Results From the Targeted Agent and Profiling Utilization Registry StudyGordan Srkalovic, Michael Rothe, Pam K Mangat, et al.
AIDS (London, England)|August 23, 2018
Aging and the evolution of comorbidities among HIV-positive individuals in a European cohortAnnegret Pelchen-Matthews, Lene Ryom, Álvaro H Borges, et al.
JCO Precision Oncology|November 21, 2022
Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With <i>BRAF</i> Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) StudyKelsey A Klute, Michael Rothe, Elizabeth Garrett-Mayer, et al.
HIV Medicine|December 10, 2021
The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA studyAmanda Mocroft, Jose M Miro, Gilles Wandeler, et al.
Pageof 51